Guidance for Meridian Bioscience Inc. (VIVO)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2022 | $0.98 – $1.08 | $1.63 | $285.00M – 300.00M | $310.00M | = Maintained | Details |
| 2022 | $1.10 – $1.30 | $1.04 | $315.00M – 330.00M | $288.00M | = Maintained | Details |
| 2022 | $1.30 – $1.40 | $1.37 | $330.00M – 345.00M | $337.00M | = Maintained | Details |
| 2021 | $1.14 – $1.28 | $1.02 | $290.00M – 310.00M | $249.15M | = Maintained | Details |
| 2021 | $1.60 – $1.80 | $1.66 | $305.00M – 335.00M | $324.00M | = Maintained | Details |
| 2020 | $0.28 – $0.34 | $0.30 | N/A | N/A | = Maintained | Details |
| 2019 | $0.74 – $0.76 | $0.77 | N/A | N/A | = Maintained | Details |
| 2019 | $0.63 – $0.65 | $0.56 | N/A | N/A | = Maintained | Details |
| 2019 | $0.74 – $0.76 | $0.76 | N/A | N/A | = Maintained | Details |
| 2018 | $0.69 – $0.72 | $0.70 | N/A | N/A | = Maintained | Details |
| 2018 | $209.00 – $214.00 | N/A | $0.69M – 0.72M | N/A | = Maintained | Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2017 | $0.64 – $0.69 | N/A | $193.00M – 199.00M | N/A | = Maintained | Details |
| 2017 | $0.64 – $0.69 | $0.82 | $193.00M – 199.00M | $206.10M |  Lowered |
Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2016 | $0.86 – $0.90 | $0.88 | $195.00M – 200.00M | $203.30M | = Maintained | Details |
| 2014 | $0.85 – $0.90 | $0.97 | $190.00M – 195.00M | $201.05M | Lowered |
Details |
| 2014 | $0.98 – $1.03 | $1.00 | $203.00M – 208.00M | $205.05M | = Maintained | Details |
| 2011 | $0.77 – $0.82 | $0.78 | $165.00M – 170.00M | $165.55M | = Maintained | Details |
| 2011 | $0.68 – $0.71 | $0.79 | N/A | N/A | Lowered |
Details |
